Skip to content

Clinical trials

Phase 3 Urinary Bladder Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 3 Country / region: United States Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20041
20052
20074
20081
20091
20103
20112
20121
20141
20155
20163
20171
20186
20198
20204
20215
20222
20233
20243
20253
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Active, not recruiting17
Terminated13
Recruiting11
Withdrawn4
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Spectrum Pharmaceuticals, Inc6
Merck Sharp & Dohme LLC5
AstraZeneca4
Memorial Sloan Kettering Cancer Center4
National Cancer Institute (NCI)4
SWOG Cancer Research Network4
UroGen Pharma Ltd.4
Alliance for Clinical Trials in Oncology3
Bristol-Myers Squibb3
Photocure3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms77
Non-Muscle Invasive Bladder Neoplasms16
Carcinoma, Transitional Cell15
Neoplasms8
Urethral Neoplasms6
Urologic Neoplasms5
Carcinoma in Situ3
Neoplasm Metastasis3
Neoplasms by Site3
Urinary Bladder Diseases3

Trials

Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.